AI Article Synopsis

  • Current asthma guidelines recommend using diaries for patients with uncontrolled symptoms or those starting new treatments, but understanding their use is limited.
  • A study analyzed data from 424 women with asthma to identify factors linked to diary use, using statistical methods.
  • Findings revealed that older age and higher education were positively associated with diary use, while more severe asthma and a smoking history were linked to diary nonuse.

Article Abstract

Background: Current asthma guidelines encourage the use of an asthma diary for patients whose symptoms are not under control, who are being introduced to new treatments, or who need help in identifying environmental or occupational exposures. Despite the potential benefit of diaries in asthma management, gaps in the understanding of their use exist. Our objective was to identify demographic and clinical characteristics predictive of diary use by women with asthma as women patients predominate in asthma among adults and have higher rates of associated asthma management problems.

Methods: Demographic and clinical characteristics associated with the use of a structured asthma diary were examined using data collected from 424 women with asthma over 18 years of age taking part in a randomized controlled study. Data were analyzed using chi-square statistics and logistic regression. Data reported are for women randomized to the intervention arm (N = 424) who were assigned the diary as part of the educational intervention.

Results: Older age (OR = 1.614; p < 0.05) and higher education (OR = 1.835; p < 0.05) were associated with diary use. More severe asthma (OR = 0.479; p < 0.01) and a history of smoking (OR = 0.495; p < 0.05) were associated with nonuse of the diary.

Conclusions: Both demographic and clinical characteristics are associated with asthma diary use. Clinicians and researchers should anticipate potential differences in use of an asthma diary according to demographic and/or clinical characteristics of female patients.

Download full-text PDF

Source
http://dx.doi.org/10.1080/02770900801956405DOI Listing

Publication Analysis

Top Keywords

clinical characteristics
20
asthma diary
20
demographic clinical
16
asthma
12
characteristics predictive
8
diary
8
diary women
8
asthma management
8
women asthma
8
associated asthma
8

Similar Publications

[Approach to Scabies in Children: An Update].

Acta Med Port

January 2025

Serviço de Dermatologia. Unidade Local de Saúde Santo António. Porto. Portugal.

Scabies is a common dermatological infection that globally affects more than 200 million people. It is caused by the parasite Sarcoptes scabiei var. hominis and its transmission primarily occurs through direct contact.

View Article and Find Full Text PDF

Plasma phosphorylated tau biomarkers open unprecedented opportunities for identifying carriers of Alzheimer's disease pathophysiology in early disease stages using minimally invasive techniques. Plasma p-tau biomarkers are believed to reflect tau phosphorylation and secretion. However, it remains unclear to what extent the magnitude of plasma p-tau abnormalities reflects neuronal network disturbance in the form of cognitive impairment.

View Article and Find Full Text PDF

Background Aims: SBP leads to high rates acute kidney injury (AKI) -hepatorenal syndrome and mortality. Population-based studies on contemporary SBP epidemiology are needed to inform care. In a large, national cohort of patients diagnosed with SBP and confirmed by ascitic fluid criteria, we characterized ascitic fluid characteristics, in-hospital and 12-month mortality, AKI, and recurrent SBP.

View Article and Find Full Text PDF

Purpose: Mobocertinib is an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that targets exon 20 insertion (ex20ins) mutations in non-small cell lung cancer (NSCLC). This open-label, phase III trial (EXCLAIM-2: ClinicalTrials.gov identifier: NCT04129502) compared mobocertinib versus platinum-based chemotherapy as first-line treatment of ex20ins+ advanced/metastatic NSCLC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!